Scarica l'app Stockscreener
6.26
2.29%
0.15
Dopo l'orario di chiusura:
6.25
-0.010
-0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$6.11
Aprire:
$6.16
Volume 24 ore:
2.19M
Relative Volume:
0.57
Capitalizzazione di mercato:
$1.55B
Reddito:
$427.68M
Utile/perdita netta:
$-58.06M
Rapporto P/E:
-26.28
EPS:
-0.2382
Flusso di cassa netto:
$-37.50M
1 W Prestazione:
+2.63%
1M Prestazione:
+5.04%
6M Prestazione:
+5.40%
1 anno Prestazione:
+57.43%
Intervallo 1D:
$6.08
$6.295
Intervallo di 1 settimana:
$6.06
$6.44
Portata 52W:
$3.49
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.26 | 1.51B | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
435.95 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.12 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
This Insider Has Just Sold Shares In Ardelyx - simplywall.st
Ardelyx Inc Live Share Prices and Trades. ARDX.US Live Streaming Share Prices. - London South East
Ardelyx (ARDX) price target increased by 12.82% to 13.46 - MSN
Ardelyx chief patient officer sells $43,803 in shares By Investing.com - Investing.com Canada
Ardelyx chief patient officer sells $43,803 in shares - Investing.com
Tax-related Ardelyx (ARDX) insider sale covers RSU withholding needs - Stock Titan
Ardelyx (ARDX) CFO executes 1,455-share tax sell-to-cover after RSU vest - Stock Titan
Ardelyx (ARDX) officer’s RSU vesting triggers 2,306-share tax sell - Stock Titan
Ardelyx (ARDX) HR chief sells 1,846 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) Chief Commercial Officer sells 7,998 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) chief business officer logs 7,248-share tax sell-to-cover - Stock Titan
Ardelyx (ARDX) Chief Patient Officer sells 6,989 shares to cover RSU taxes - Stock Titan
Ardelyx (ARDX) CEO Raab executes 54,748-share RSU tax sell-to-cover - Stock Titan
Ardelyx president & CEO Michael Raab sells $261,612 of ARDX stock - Investing.com India
What Triggered Ardelyx's Post-Earnings Plunge - Kavout
Ardelyx Earnings Call Highlights Rapid Growth, Rising Costs - TipRanks
ARDX (NASDAQ: ARDX) files Form 144 for 24,986 RSUs vesting - Stock Titan
ARDX (NASDAQ: ARDX) reports 5,355 RSUs vest; insider sales noted - Stock Titan
James Parker Brady files Form 144 for 6,216 ARDX shares (ARDX) - Stock Titan
Proposed Common Stock Sale by ARDX Affiliate (NASDAQ: ARDX) - Stock Titan
ARDX (NASDAQ) insider reports 10,388 RSUs vesting; prior sales 4,991 shares - Stock Titan
Michael Raab reports multiple ARDX share sales (ARDX) and RSU vesting - Stock Titan
ARDX (NASDAQ: ARDX) files Form 144 for 7,771 vested RSUs and lists recent insider sales - Stock Titan
Ardelyx Insider Sold Shares Worth $261,612, According to a Recent SEC Filing - Moomoo
Insider sale reported for ARDX (ARDX): 24,041 RSU shares vest - Stock Titan
Ardelyx (ARDX) CEO sells 41,666 shares in 10b5-1 trade, exercises options - Stock Titan
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026 - The Manila Times
A Look At Ardelyx (ARDX) Valuation After New Long Term XPHOZAH Data Strengthens Safety And Efficacy Profile - simplywall.st
Ardelyx, Inc.Common Stock (NQ: ARDX - The Chronicle-Journal
Ardelyx (ARDX) Is Down 8.1% After New Long-Term XPHOZAH Dialysis DataHas The Bull Case Changed? - simplywall.st
Janus Henderson (ARDX) discloses 8.37M‑share, 3.4% position in Ardelyx - Stock Titan
ARDX Stock Chart | ARDELYX INC (NASDAQ:ARDX) - ChartMill
ETFs Investing in Ardelyx, Inc. Stocks - TradingView
Ardelyx, Inc. $ARDX Stock Position Increased by Vanguard Group Inc. - MarketBeat
State Street (ARDX) reports 13.6M-share | 5.5% stake via advisory entities - Stock Titan
TradingKey - TradingKey
Assessing Ardelyx (ARDX) Valuation After New Long Term XPHOZAH Safety Data Presentation - simplywall.st
Ardelyx (ARDX) Is Up 10.3% After Long-Term XPHOZAH Safety Data In Dialysis PatientsWhat's Changed - Yahoo Finance
Why Ardelyx (ARDX) Is Up 10.3% After New Long-Term XPHOZAH Dialysis Data And What's Next - simplywall.st
Ardelyx: Low Price, But High Implied Valuation (NASDAQ:ARDX) - Seeking Alpha
Ardelyx, Inc. (ARDX) Investor Outlook: Analyzing The 134% Potential Upside - DirectorsTalk Interviews
Ardelyx presents long-term safety data for XPHOZAH at NKF meeting By Investing.com - Investing.com South Africa
Assessing Ardelyx (ARDX) Valuation After Q1 2026 Results And Reaffirmed Revenue Guidance - Yahoo Finance
Ardelyx presents long-term safety data for XPHOZAH at NKF meeting - Investing.com
Dialysis drug cut phosphate without shifting other electrolytes in trials - Stock Titan
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx - TMX Newsfile
Ardelyx (ARDX) Q1 2026 Earnings Transcript - AOL.com
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
Ardelyx (NASDAQ:ARDX) Strengthens Amid Biotech Momentum - Kalkine Media
Ardelyx, Inc. (NASDAQ:ARDX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Moomoo
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hohenleitner Susan | Chief Financial Officer |
May 21 '26 |
Sale |
6.27 |
1,455 |
9,119 |
229,078 |
| Bishop John E | See Remarks |
May 21 '26 |
Sale |
6.27 |
2,306 |
14,453 |
336,845 |
| Brady James Parker | Chief Human Resources Officer |
May 21 '26 |
Sale |
6.27 |
1,846 |
11,570 |
261,066 |
| Foster Eric Duane | Chief Commercial Officer |
May 21 '26 |
Sale |
6.27 |
7,998 |
50,127 |
417,972 |
| Kelliher Mike | Chief Business Officer |
May 21 '26 |
Sale |
6.27 |
7,248 |
45,427 |
357,418 |
| Williams Laura A | Chief Patient Officer |
May 21 '26 |
Sale |
6.27 |
6,989 |
43,804 |
429,093 |
| RAAB MICHAEL | President & CEO |
May 21 '26 |
Sale |
6.27 |
54,748 |
343,133 |
1,720,033 |
2.25%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):